Kimia Therapeutics

Kimia Therapeutics is building the next generation of drug discovery engines by combining Chemotype Evolution with state-of-the-art computational methods to identify drug pathways for major diseases. Chemotype Evolution (CE) enables the rapid synthesis and screening of target-focused chemical libraries, providing highly relevant, information-rich datasets well-suited for machine learning (ML). Kimia will apply ML-powered CE to overcome the limitations of current technologies and accelerate drug discovery for both validated and challenging targets. Additionally, Kimia will utilize ML-powered CE to explore biological pathways and identify drugs for novel targets associated with cancer and immune diseases.